Literature DB >> 10627816

Structure of the crystallins.

C Slingsby1, N J Clout.   

Abstract

The lens is formed from two protein superfamilies, the alpha- and beta gamma-crystallins. Representative three-dimensional structures show they both have a basic 2-beta-sheet domain fold, with the beta gamma-domain being made from two intercalating Greek keys. X-ray structures of monomeric gamma-crystallins and simple oligomeric beta-crystallins show how multiple gene duplications can give rise to highly symmetrical assemblies based on paired domains. These protein folds have been engineered by directed mutagenesis to investigate the roles of the critical region in domain pairing and assembly. Inherited human cataracts have been described that are associated with representatives of each of the crystallin protein families. Mutations to certain beta- and gamma-crystallin genes cause expression of truncated polypeptides that would not be expected to fold properly; instead they would randomly aggregate causing light scattering. As crystallin proteins are not renewed, age-related cataract is a gradual accumulation of small changes to pre-existing normal proteins. The precise sites of post-translational modifications are now being mapped to the various crystallins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10627816     DOI: 10.1038/eye.1999.113

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  29 in total

1.  New class of cargo protein in Tetrahymena thermophila dense core secretory granules.

Authors:  Alex Haddad; Grant R Bowman; Aaron P Turkewitz
Journal:  Eukaryot Cell       Date:  2002-08

2.  Cataract-linked γD-crystallin mutants have weak affinity to lens chaperones α-crystallins.

Authors:  Sanjay Mishra; Richard A Stein; Hassane S McHaourab
Journal:  FEBS Lett       Date:  2012-01-28       Impact factor: 4.124

3.  Analysis of betaB1-crystallin unfolding equilibrium by spin and fluorescence labeling: evidence of a dimeric intermediate.

Authors:  Hanane A Koteiche; M Satish Kumar; Hassane S McHaourab
Journal:  FEBS Lett       Date:  2007-04-12       Impact factor: 4.124

4.  Folding and stability of the isolated Greek key domains of the long-lived human lens proteins gammaD-crystallin and gammaS-crystallin.

Authors:  Ishara A Mills; Shannon L Flaugh; Melissa S Kosinski-Collins; Jonathan A King
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

5.  Electrostatic origin of in vitro aggregation of human γ-crystallin.

Authors:  Benjamin G Mohr; Cassidy M Dobson; Scott C Garman; Murugappan Muthukumar
Journal:  J Chem Phys       Date:  2013-09-28       Impact factor: 3.488

6.  Novel mutations in CRYBB1/CRYBB2 identified by targeted exome sequencing in Chinese families with congenital cataract.

Authors:  Peng Chen; Hao Chen; Xiao-Jing Pan; Su-Zhen Tang; Yu-Jun Xia; Hui Zhang
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

7.  Modifications of human betaA1/betaA3-crystallins include S-methylation, glutathiolation, and truncation.

Authors:  Veniamin N Lapko; Ronald L Cerny; David L Smith; Jean B Smith
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

8.  A deletion mutation in the betaA1/A3 crystallin gene ( CRYBA1/A3) is associated with autosomal dominant congenital nuclear cataract in a Chinese family.

Authors:  Yanhua Qi; Hongyan Jia; Shangzhi Huang; Hui Lin; Jingzhi Gu; Hong Su; Tieying Zhang; Ya Gao; Lijun Qu; Dandan Li; Ying Li
Journal:  Hum Genet       Date:  2003-11-04       Impact factor: 4.132

9.  Solution properties of γ-crystallins: compact structure and low frictional ratio are conserved properties of diverse γ-crystallins.

Authors:  Yingwei Chen; Huaying Zhao; Peter Schuck; Graeme Wistow
Journal:  Protein Sci       Date:  2013-11-28       Impact factor: 6.725

10.  Hydrophobic core mutations associated with cataract development in mice destabilize human gammaD-crystallin.

Authors:  Kate L Moreau; Jonathan King
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.